PAR1 expression on breast cancer cells has been associated with a high metastatic potential, and inhibiting the downstream signals from PAR1, using a small molecule inhibitor, suppressed Akt-mediated survival pathways, and attenuated tumor growth and experimental lung metastasis [47]. The gene discussed is AKT1; the disease is breast carcinoma.